Anticonvulsant action of GBR-12909 and citalopram against acute experimentally induced limbic seizures

Neuropharmacology

Volumn 47, Issue 7, 2004, Pages 1053-1061

  Clinckers, Ralph ^a   Smolders, Ilse ^a   Meurs, Alfred ^a   Ebinger, Guy ^a   Michotte, Yvette ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Depression; Dopamine; Epilepsy; Hippocampus; Microdialysis; Pilocarpine; Serotonin

Indexed keywords

CITALOPRAM; DOPAMINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; REMOXIPRIDE; SEROTONIN; UNCLASSIFIED DRUG; VANOXERINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPLEX PARTIAL SEIZURE; CONTROLLED STUDY; DOPAMINE RELEASE; HIPPOCAMPUS; MALE; NEUROPROTECTION; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RAT;

ACUTE DISEASE; ANIMALS; ANTICONVULSANTS; BIOGENIC MONOAMINES; CITALOPRAM; DOPAMINE; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; LIMBIC SYSTEM; MALE; MICRODIALYSIS; MUSCARINIC AGONISTS; PILOCARPINE; PIPERAZINES; PYRIDINES; RATS; RATS, WISTAR; REMOXIPRIDE; SEIZURES; SEROTONIN; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS;

EID: 8844236235     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2004.07.032     Document Type: Article

References (39)

1. Alam A.M., Starr M.S. Dopaminergic modulation of pilocarpine-induced motor seizures in the rat: the role of hippocampal D2 receptors. Neuroscience. 53:(2):1993;425-431
2. Andersen P.H. The dopamine inhibitor GBR 12909: selectivity and molecular mechanism of action. European Journal of Pharmacololgy. 166:1989;493-504
3. Arai S., Morita K., Kitayama S., Kumagai K., Kumagai M., Kihira K., Dohi T. Chronic inhibition of the norepinephrine transporter in the brain participates in seizure sensitization to cocaine and local anesthetics. Brain Research. 964:2003;83-90
4. Bergles D.E., Doze V.A., Madison D.V., Smith S.J. Excitatory actions of norepinephrine on multiple classes of hippocampal CA1 interneurons. Journal of Neuroscience. 16:1996;572-585
5. Clinckers, R., Smolders, I., Meurs, A., Ebinger, G., Michotte, Y., 2004. Anticonvulsant effect of hippocampal dopamine and serotonin is independently mediated by D2 and 5-HT1A receptors. Journal of Neurochemistry, 89 (4), 834-843.
6. Cremers T.I., de Boer P., Liao Y., Bosker F.J., den Boer J.A., Westerink B.H., Wikstrom H.V. Augmentation with a 5-HT(1A), but not a 5-HT(1B) receptor antagonist critically depends on the dose of citalopram. European Journal of Pharmacology. 397:2000;63-74
7. De Montis G.M., Devoto P., Gessa G.L., Meloni D., Porcella A., Saba P., Serra G., Tagliamonte A. Central dopaminergic transmission is selectively increased in the limbic system of rats chronically exposed to antidepressants. European Journal of Pharmacology. 180:1990;31-35
8. Favale E., Rubino V., Mainardi P., Lunardi G., Albano C. Anticonvulsant effect of fluoxetine in humans. Neurology. 45:1995;1926-1927
9. Hyttel J. Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs). International Clinical Psychopharmacology. 9:(Suppl. 1):1994;19-26
10. Jobe P.C., Dailey J.W., Wernicke J.F. A noradrenergic and serotonergic hypothesis of the linkage between epilepsy and affective disorders. Critical Reviews in Neurobiology. 13:1999;317-356
11. Jobe P.C. Common pathogenic mechanisms between depression and epilepsy: an experimental perspective. Epilepsy and Behavior. 4:(Suppl 3):2003;S14-S24
12. Kabuto H., Yokoi I., Endo A., Takei M., Kurimoto T., Mori A. Chronic administration of citalopram inhibited El mouse convulsions and decreased monoamine oxidase-A activity. Acta Medica Okayama. 48:1994;311-316
13. Kanner A.M., Balabanov A. Depression and epilepsy: how closely related are they? Neurology. 58:2002;27-39
14. Khan G.H, Smolderes I., Ebinger G., Michote Y. 2-chloro-N(6)-cyclopentyl- adenosine-elicited attenuation of evoked glutamate release is not sufficient to give complete protection against pilocarpine-induced seizures in rats. Neuropharmacology. 40:(5):2001;657-667
15. Klimek V., Schenck J.E., Han H., Stockmeier C.A., Ordway G.A. Dopaminergic abnormalities in amygdaloid nuclei in major depression: a postmortem study. Biological Psychiatry. 52:2002;740-748
16. Lemonde S., Turecki G., Bakish D., Du L., Hrdina P.D., Bown C.D., Sequeira A., Kushwaha N., Morris S.J., Basak A., Ou X.M., Albert P.R. Impaired repression at a 5-hydroxy tryptamine 1A receptor gene polymorphism associated with major depression and suicide. Journal of Neuroscience. 23:2003;8788-8799
17. Lu K.T., Gean P.W. Endogenous serotonin inhibits epileptiform activity in rat hippocampal CA1 neurons via 5-hydroxy tryptamine1A receptor activation. Neuroscience. 86:1998;729-737
18. Mike A., Karoly R., Vizi E.S., Kiss J.P. Inhibitory effect of the DA uptake blocker GBR 12909 on sodium channels of hippocampal neurons. Neuroreport. 14:(15):2003;1945-1949
19. Mike A., Karoly R., Vizi E.S., Kiss J.P. A novel modu latory mechanism of sodium currents: frequency-dependence without state-dependent binding. Neuroscience. 125:(4):2004;1019-1028
20. Muldoon C. The safety and tolerability of citalopram. International Clinical Psychopharmacology. 11:(Suppl 1):1996;35-40
21. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. second ed.:1986;Academic Press, San Diego, CA
22. Personne M., Persson H., Sjoberg E. Citalopram toxicity. Lancet. 350:1997;518-519
23. Piacentini M.F., Clinckers R., Meeusen R., Sarre S., Ebinger G., Michotte Y. Effect of bupropion on hippocampal neurotransmitters and on peripheral hormonal concentrations in the rat. Journal of Applied Physiology. 95:2003a;652-656
24. Piacentini M.F., Clinckers R., Meeusen R., Sarre S., Ebinger G., Michotte Y. Effects of venlafaxine on extracellular 5-HT, dopamine and noradrenaline in the hippocampus and on peripheral hormone concentrations in the rat in vivo. Life Sciences. 73:2003b;2433-2442
25. Pisani F., Spina E., Oteri G. Antidepressant drugs and seizure susceptibility: from in vitro data to clinical practice. Epilepsia. 40:(Suppl. 10):1999;48-56
26. Pralong E., Magistretti P., Stoop R. Cellular perspectives on the glutamate-monoamine interactions in limbic lobe structures and their relevance for some psychiatric disorders. Progress in Neurobiology. 67:2002;173-202
27. Preskorn S.H., Fast G.A. Tricyclic antidepressant-induced seizures and plasma drug concentration. Journal of Clinical Psychiatry. 53:1992;160-162
28. Racine R.J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalographic Clinical Neurophysiology. 32:1972;281-294
29. Salgado D., Alkadhi K.A. Inhibition of epileptiform activity by serotonin in rat CA1 neurons. Brain Research. 669:1995;176-182
30. Sarre S., Thorre K., Smolders I., Michotte Y. Microbore liquid chromatography analysis of monoamine transmitters. Methods in Molecular Biolology. 72:1997;185-196
31. Scanziani M., Gahwiler B.H., Thompson S.M. Presynaptic inhibition of excitatory synaptic transmission mediated by alpha adrenergic receptors in area CA3 of the rat hippocampus in vitro. Journal of Neuroscience. 13:1993;5393-5401
32. Smolders I., Sarre S., Michotte Y., Ebinger G. The analysis of excitatory, inhibitory and other amino acids in rat brain microdialysates using microbore liquid chromatography. Journal of Neuroscience Methods. 57:1995;47-53
33. Smolders I., Khan G.M., Manil J., Ebinger G., Michotte Y. NMDA receptor-mediated pilocarpine-induced seizures: characterization in freely moving rats by microdialysis. British Journal of Pharmacology. 121:1997;1171-1179
34. Stahl S. 5HT1A receptors and pharmacotherapy. Is serotonin receptor down-regulation linked to the mechanism of action of antidepressant drugs? Psychopharmacology Bulletin. 30:1994;39-43
35. Swinkels J.A., de Jonghe F. Safety of antidepressants. International Clinical Psychopharmacology. 9:(Suppl. 4):1995;19-25
36. Vaishnavi S.N., Nemeroff C.B., Plott S.J., Rao S.G., Kranzler J., Owens M.J. Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity. Biological Psychiatry. 55:2004;320-322
37. Vizi E.S., Kiss J.P. Neurochemistry and pharmacology of the major hippocampal transmitter systems: synaptic and nonsynaptic interactions. Hippocampus. 8:1998;566-607
38. Wegener G., Linnet K., Rosenberg R., Mork A. The effect of acute citalopram on extracellular 5-HT levels is not augmented by lithium: an in vivo microdialysis study. Brain Research. 871:2000;338-342
39. Witkin J.M., Dijkstra D., Levant B., Akunne H.C., Zapata A., Peters S., Shannon H.E., Gasior M. Protection against cocaine toxicity in mice by the dopamine D3/D2 agonist R-(+)-trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1] benzopyrano[4,3-b]-1,4-o xazin-9-ol [(+)-PD 128,907]. Journal of Pharmacology and Experimental Therapeutics. 308:2004;957-964